Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
J., Asahina, K
The most commonly reported side effects were gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, which were generally mild to moderate and most frequent during the dose-escalation phase
Increased Risk of Serious Complications While rare, there are more serious risks associated with GLP-1 and GIP receptor agonists
6 Current estimates suggest that up to 10% of the general adult population in both Europe and North America is affected by restless leg syndrome, a condition characterized by the irresistible restlessness and urge to move the legs, particularly at night
Novo Nordisk holds protection until 2032 in the United States and until 2031 in both Japan and Europe, according to its annual report
US$ 22.22
US$ 28.10
US$ 26.19
US$ 21.83
US$ 25.83
